EEBA Program (PDF/3MB) - EEBA - Annual Meeting
EEBA Program (PDF/3MB) - EEBA - Annual Meeting EEBA Program (PDF/3MB) - EEBA - Annual Meeting
MID-TERM RESULTS ON VISUAL ACUITY AND STABILITY AFTER DESCEMET MEMBRANEENDOTHELIAL KERATOPLASTY (DMEK)E. A. Groeneveld-van Beek1,2, L. Ham1,3, K. van Dijk1,3, I. Dapena1,3, G. R.J. Melles1,2,31Netherlands Institute for Innovative Ocular Surgery; 2Amnitrans EyeBank Rotterdam; 3Melles Cornea ClinicRotterdam, The NetherlandsPurpose: To report on the mid-term visual outcomes and stability after Descemet membraneendothelial keratoplasty (DMEK).Methods: DMEK was performed for Fuchs endothelial dystrophy, bullous keratopathy or previouscorneal transplant failure in 300 consecutive eyes The best corrected visual acuity (BCVA) wasdocumented before, and after surgery at 1, 6, and 12 months, and annually thereafter.Results: 97.4% of eyes reached a BCVA of ≥20/40 (0.5) within the first months after surgery, which wassustained over 5 years. A BCVA of ≥20/25 (≥0.8) was reached by 77.6% at 6 months (n=228), and 87.5at 5 years (n=8). A BCVA of ≥20/20 (≥1.0) was obtained by 45.6% at 6 months and 62.5% at 5 years.Furthermore, a BCVA of even ≥20/17 (≥1.2) was obtained by 14.5% at 6 months and 12.5% at 5 years.Conclusions: DMEK provides a fast and often complete visual recovery. Furthermore these visualoutcomes appear to remain stable for at least 5 years after surgery. Thus, DMEK surgery seems tosurpass other EK techniques in visual rehabilitation and final visual outcome.44
ENDOTHELIAL CELL DENSITY AFTER DESCEMET MEMBRANE ENDOTHELIAL KERATOPLASTY(DMEK): 1 TO 6 - YEAR FOLLOW-UPK. Mangundap, L. Ham, L. Baydoun, K. van Dijk, G. MellesNetherlands Institute for Innovative Ocular Surgery, The NetherlandsPurpose: To assess the rate of decline in endothelial cell density (ECD) for patients up to 6 years afterDescemet membrane endothelial keratoplasty (DMEK).Methods: From a larger group of 300 consecutive patients who underwent DMEK for Fuchsendothelial dystrophy or pseudophakic bullous keratopathy, ECD measurements were available for254 eyes with 6 months follow-up; for 234 eyes with 1 year follow-up; 130 with 2 years follow-up; 63with 3 years follow-up; 25 with 4 years follow-up; 9 with 5 years follow-up, and 7 eyes with 6 yearsfollow-up.Results: Our findings show a 35% sharp decrease in ECD in the first 6 months after DMEK, followed byan annual decrease of approximately 9%.Conclusions: The rate of endothelial cell loss in patients up to 6 years after DMEK closely resemblesthe published reports for patients after alternate forms of endothelial keratoplasty. This, combinedwith evidence that >¾ of patients achieve visual outcomes of ≥20/25 (≥0.8) at 6 months after surgery,may indicate that DMEK could become a preferred treatment method in corneal endothelial disease.XXV ANNUAL MEETING OF THE EUROPEAN EYE BANK ASSOCIATION Zagreb, Croatia 18/19 January 2013 45
- Page 1 and 2: XXV ANNUAL MEETING OFTHE EUROPEAN E
- Page 3 and 4: IntroductionDear Colleagues and Fri
- Page 5 and 6: Program OverviewFriday 18 January 2
- Page 9: 16.29 - 16.37 Christina Sanchez Mil
- Page 13: 10.08 - 10.16 François Majo¹, M.
- Page 16 and 17: fi fi
- Page 18 and 19: fi fi
- Page 21 and 22: Accommodation & TravelingZagrebThe
- Page 23 and 24: Accommodation & TravelingHow to get
- Page 25 and 26: Table of contentsINVITED LECTURE: T
- Page 27 and 28: INVITED LECTURE: THOMAS REINHARD, G
- Page 29 and 30: EUROCET 128: SUPPORTING THE IMPLEME
- Page 31 and 32: MENTAL ATTITUDES CONCERNING CORNEA
- Page 33 and 34: AN EVALUATION OF TOTAL BLOOD AND PL
- Page 35 and 36: USE OF FIVE-YEAR CORNEAL GRAFT SURV
- Page 37 and 38: PRECUTTING OF DONOR CORNEAS FOR POS
- Page 39 and 40: STUDY OF STROMAL FEMTOSECOND LASER
- Page 41 and 42: ULTRA- THIN DESCEMET STRIPPING AUTO
- Page 43: POSTERIOR LAMELLAR KERATOPLASTY- PO
- Page 47 and 48: INVITED LECTURE: DONALD TAN, SINGAP
- Page 49 and 50: INTEGRITY OF HUMAN CORNEAL EPITHELI
- Page 51 and 52: A NOVEL OBJECTIVE METHOD TO EVALUAT
- Page 53 and 54: EVALUATION OF DONOR CORNEAS DURING
- Page 55 and 56: DELIVERY OF MOLECULES INTO CORNEAL
- Page 57 and 58: VISIONGRAFT® STERILE CORNEA - NEW
- Page 59 and 60: EMERGENCY PREPAREDNESSP. DahlThe Ey
- Page 61 and 62: MANAGEMENT IN NON-TRAUMATIC CORNEAL
- Page 63 and 64: CATARACT AND FUCH’S DYSTROPHY: DS
- Page 65 and 66: RECURRENCE OF ANTERIOR CORNEAL DYST
- Page 67 and 68: USE OF ANTI-VEGF (BEVACIZUMAB) AFTE
- Page 69 and 70: INVITED LECTURE: KEVIN CORCORAN, US
- Page 71 and 72: IDENTIFICATION OF LABEL-RETAINING E
- Page 73 and 74: EPITHELIAL AND PROGENITOR CELL MARK
- Page 75 and 76: INFLUENCE OF STORAGE CONDITIONS OF
- Page 77 and 78: PostersRESULTS OF MORPHOLOGICAL EXA
- Page 79 and 80: KERATOPLASTY “A CHAUD“D. Saric,
- Page 81 and 82: CELL-BY-CELL ALIGNMENT OF REPEATED
- Page 83 and 84: RIGID GAS-PERMEABLE CONTACT LENS CO
- Page 85 and 86: DEEP ANTERIOR LAMELLAR KERATOPLASTY
- Page 87 and 88: CORECTION OF POST-KERATOPLASTY ASTI
- Page 90: yChoose the highestquality for your
ENDOTHELIAL CELL DENSITY AFTER DESCEMET MEMBRANE ENDOTHELIAL KERATOPLASTY(DMEK): 1 TO 6 - YEAR FOLLOW-UPK. Mangundap, L. Ham, L. Baydoun, K. van Dijk, G. MellesNetherlands Institute for Innovative Ocular Surgery, The NetherlandsPurpose: To assess the rate of decline in endothelial cell density (ECD) for patients up to 6 years afterDescemet membrane endothelial keratoplasty (DMEK).Methods: From a larger group of 300 consecutive patients who underwent DMEK for Fuchsendothelial dystrophy or pseudophakic bullous keratopathy, ECD measurements were available for254 eyes with 6 months follow-up; for 234 eyes with 1 year follow-up; 130 with 2 years follow-up; 63with 3 years follow-up; 25 with 4 years follow-up; 9 with 5 years follow-up, and 7 eyes with 6 yearsfollow-up.Results: Our findings show a 35% sharp decrease in ECD in the first 6 months after DMEK, followed byan annual decrease of approximately 9%.Conclusions: The rate of endothelial cell loss in patients up to 6 years after DMEK closely resemblesthe published reports for patients after alternate forms of endothelial keratoplasty. This, combinedwith evidence that >¾ of patients achieve visual outcomes of ≥20/25 (≥0.8) at 6 months after surgery,may indicate that DMEK could become a preferred treatment method in corneal endothelial disease.XXV ANNUAL MEETING OF THE EUROPEAN EYE BANK ASSOCIATION Zagreb, Croatia 18/19 January 2013 45
Change language